Dietary supplementation with pressurized whey in patients with cystic fibrosis

Journal of Medicinal Food

Volumn 13, Issue 1, 2010, Pages 77-82

  Lands, L C ^a   Iskandar, M ^a   Beaudoin, N ^b   Meehan, B ^a   Dauletbaev, N ^a   Berthiuame, Y ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Glutathione; Inflammation; Interleukin 8; Nutrition

Indexed keywords

C REACTIVE PROTEIN; GLUTATHIONE; INTERLEUKIN 6; INTERLEUKIN 8; PHYTOHEMAGGLUTININ;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; INFECTION COMPLICATION; LUNG FUNCTION; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; NUTRITIONAL VALUE; PRESSURIZED WHEY; PRIORITY JOURNAL; PROTEIN DIET; RASH; SCHOOL CHILD; TREATMENT DURATION; WHEY;

EID: 76649145427     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0326     Document Type: Article

References (40)

1. Anselmo MA, Lands LC: Cystic fibrosis: overview. In: Pediatric Respiratory Medicine, 2nd ed. (Taussig LM, Landau LI, eds.). Mosby, Philadelphia, 2008, pp. 845-857.
2. Elizur A, Cannon CL, Ferkol TW: Airway inflammation in cystic fibrosis. Chest 2008;133:489-495.
3. Sagel SD, Sontag MK, Wagener JS, Kapsner RK, Osberg I, Accurso FJ: Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. J Pediatr 2002;141: 811-817.
4. Smountas AA, Lands LC, Mohammed SR, Grey V: Induced sputum in cystic fibrosis: within week reproducibility of inflammatory markers. Clin Biochem 2004;37:1031-1036.
5. Birrer P, McElvaney NG, Rüdeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG: Proteaseantiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150:207-213.
6. Buhl R, Meyer A, Vogelmeier C: Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. Chest 1996;110 (6 Suppl):267S-272S.
7. Starosta V, Rietschel E, Paul K, Baumann U, Griese M: Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 2006;129:431-437.
8. Voynow JA, Fischer BM, Zheng S: Proteases and cystic fibrosis. Int J Biochem Cell Biol 2008;40:1238-1245.
9. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, Roos D, Griese M: Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007;13: 1423-1430.
10. Leavy O: Lung inflammation: disarming neutrophils in cystic fibrosis. Nat Rev Immunol 2008;8:8.
11. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV: A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995;126:515-523.
12. Lands LC, Milner R, Cantin AM, Manson D, Corey M: Highdose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. J Pediatr 2007;151:249-254.
13. Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK: Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. Pediatr Infect Dis J 2007;26:8-12.
14. Lands LC, Grey V, Smountas AA, Kramer VG, McKenna D: Lymphocyte glutathione levels in children with cystic fibrosis. Chest 1999;116:201-205.
15. Visca A, Bishop CT, Hilton SC, Hudson VM: Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study. J Cyst Fibros 2008;7: 433-436.
16. Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB, Herzenberg LA: High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl Acad Sci U S A 2006;103:4628-4633.
17. Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC: Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros 2003;2: 195-198.
18. Lopez-Fandino R: Functional improvement of milk whey proteins induced by high hydrostatic pressure. Crit Rev Food Sci Nutr 2006;46:351-363.
19. Jing Y: Mechanisms by which whey supplementation increases hepatic glutathione concentrations [Master's thesis]. McGill University, Montreal, 2004.
20. Vilela RM, Lands LC, Chan HM, Azadi B, Kubow S: High hydrostatic pressure enhances whey protein digestibility to generate whey peptides that improve glutathione status in CFTR-deficient lung epithelial cells. Mol Nutr Food Res 2006;50:1013-1029.
21. Zavorsky GS, Kubow S, Grey V, Riverin V, Lands LC: An openlabel dose response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements. Int J Food Sci Nutr 2007;58:429-436.
22. Morris JF, Koski A, Johnson LC: Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971;103:57-67.
23. Geukers VGM, Oudshoorn JH, Taminiau JA, van der Ent CK, Schilte P, Ruiter AF, Ackermans MT, Endert E, Jonkers-Schuitema CF, Heymans HS, Sauerwein HP: Short-term protein intake and stimulation of protein synthesis in stunted children with cystic fibrosis. Am J Clin Nutr 2005;81:605-610.
24. Durnin JVGA, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:277-297.
25. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS=ERS Task Force: Standardisation of spirometry. Eur Respir J 2005;26:319-338.
26. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-522.
27. Anderson ME: Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985;113:548-555.
28. Dauletbaev N, Rickmann J, Viel K, Diegel H, von Mallinckrodt C, Stein J, Wagner TO, Bargon J: Antioxidant properties of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 2005; 288:L903-L909.
29. De Groote D: Direct stimulation of cytokines (IL-1 beta, TNFalpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4: 239-248.
30. Lands LC, Hornby L, Hohenkerk JM, Glorieux FH: Accuracy of measurements of small changes in soft tissue mass by dualenergy absorptiometry. Clin Invest Med 1996;19:279-285.
31. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-2242.
32. Hanning RM, Blimkie CJ, Bar-Or O, Lands LC, Moss LA, Wilson WM: Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference? Am J Clin Nutr 1993;57:580-587.
33. Kalnins D, Corey M, Ellis L, Pencharz PB, Tullis E, Durie PR: Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. J Pediatr 2005;147:399-401.
34. Otterbein LE, Choi AMK: The saga of leucine zippers continues: in response to oxidative stress. Am J Respir Cell Mol Biol 2002; 26:161-163.
35. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ, Hodson ME, Anker SD, Henein MY: Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001;56:746-750.
36. Nicodemo A, Ismail AA, Landau LC, Kubow S: The effects of whey proteins on lipoprotein metabolism and oxidative stress: a review of human and animal studies. Recent Res Dev Lipids 2000;4:245-302.
37. Janeway CA, Travers P: Immunobiology: The Immune System in Health and Disease, 3rd ed. Current Biology Ltd., London, 1997.
38. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL: Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol 1999; 65:291-298.
39. Konstan MW, Byard PJ, Hoppel CL, Davis PB: Effect of highdose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-854.
40. Lands LC, Stanojevic S: Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Cochrane Database Syst Rev 2007;4:CD001505.